Prescribing patterns and communication for oxycodone on ED discharge

Grant ID: EMTR-200R26-2016

Lay Summary

There are growing public health concerns that opioid medications are being increasingly and excessively prescribed. These medications may have a serious side effect profile including sedation, tolerance, and development of addiction, and may subsequently be diverted in the community for non-medical use.

The objective of this study is to evaluate the effectiveness of an intervention for discharge oxycodone prescribing relevant to Australian Emergency Departments. The principal aims are to decrease the amount of oxycodone prescribed, improve practitioner awareness of local opioid prescribing behaviour, and improve documentation around oxycodone use on discharge.

This quality assurance evaluation study will measure the success of a multifaceted oxycodone prescribing intervention and its impact on oxycodone prescribing for patients discharged home from the Emergency Department (ED). The project is hypothesized to reduce oxycodone prescribing, improve discharge documentation, and ensure appropriate follow up plans are in place.

Pain is a common symptom in ED patients, and is often the primary reason patients seek emergency medical attention. A recent baseline audit of local prescribing records revealed oxycodone, an opioid pain medication, is prescribed in approximately 5% of patients discharged home from this ED (with an annual census of 77,500 presentations). Clinical documentation and discharge communication was either absent, incomplete, or inconsistent when discharge plans for dosing, duration of therapy, follow-up reviews and de-escalation of therapy were analysed.

To our knowledge, no published Australian data is available on oxycodone prescribing behaviours from EDs. If this project is successful, the amount of oxycodone prescribed will reduce, patients will be better informed, and the quality of medical handover to General Practitioners will improve.

With 7.4 million patient presentations to Australian EDs in 2014-15, the successful translation of an oxycodone prescribing intervention through clinical awareness and action would contribute to reducing the overall burden of opioids in the broader community


SHARE

Amount Awarded
$34,955


Program


Grant Scheme


Status
Active


Principal Investigator:
Dr Rina Savage


Co Investigators:
Ms Taylor Kline
Ms Caitlin Lock
Mrs Champika Pattullo


Supervisor:
Associate Professor Anthony Bell


Associate Investigators:
Dr Vanessa Grayson
RBWH ED Pharmacy Team Leader


Institution



CONTACT US +61 7 3720 5700 info@emfoundation.org.au 2/15 Lang Parade Milton Qld 4064